BNTX BioNTech Group Gross Profit Margin

Official company branding of BioNTech Inc. (BNTX)

BioNTech SE gross margin highlights the business protection provided by unique patents and liquidity. High efficiency is supported by sterile plants in Germany and the global expansion of capacities. The scaling model allows for the low-cost replication of expensive developments, generating profit. Currently, the parameter value is 51.00, which demonstrates the company's current operational profitability.

BNTX - BioNTech Pharma Return on Gross Profit over the range 07/04/2022 - 11/19/2026

Financial and market metric breakdowns for biontech.de (BNTX)

- current quotes and average value forecast:
Fundamental valuation:BioNTech Group (BNTX)
Signature product of BioNTech SE

Gross margin is calculated as the difference between total revenue and direct production costs. This indicator measures operational efficiency, determining the funds available to cover administrative expenses and investments. For BioNTech SE (BNTX), the value 51.00 reflects the company's ability to finance expansion into the oncology and mRNA therapy segments through current sales. The trend of the gross margin as a percentage of revenue allows for an assessment of the business model's resilience when scaling clinical trials.

Key competitors

argenx - Gross Profit Rate|ABVX (Abivax Pharma) - Gross Margin|Return on Gross Profit ADMA Bio (ADMA)|Return on Gross Profit PTGX (Protagonist Therapeutics Inc)|Gross Margin immunovant.com (IMVT)|Gross Profitability kiniksa.com KNSA|Grifols SA (GRFS) - Gross Profit Margin|Adaptive Biotechnologies Inc. - Gross Margin|Gross Profit Margin Celldex Therapeutics|AUPH: Gross Margin|BCRX - Return on Sales by Gross Profit|VERA (Vera Corp) - Gross Margin|Dianthus Pharma (DNTH) - Return on Sales by Gross Profit|Gross Profitability Pharvaris Pharma (PHVS)|Gross Margin AbCellera Corp (ABCL)|Gross Margin TRML (Tourmaline Bio Inc)|Return on Sales by Gross Profit precigen.com (PGEN)|PHAR - Gross Profitability|Gross Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Gross Profit|Zenas Corp (ZBIO) - Gross Margin|Return on Gross Profit IMNM|GOSS: Gross Profit Rate|Gross Profitability KalVista Pharma (KALV)|SEPN - Gross Profit Margin|Gross Margin PVLA (pieris.com)|Gross Margin Savara Pharma SVRA|RIGL: Return on Gross Profit|ANAB - Gross Margin|ATXS: Gross Margin|ENGN - Return on Sales by Gross Profit|Return on Gross Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Gross Profit Ratio|Gross Margin ACRS|Return on Gross Profit kyvernatx.com KYTX|Gross Margin TLSA (Tiziana Life Sciences, Ltd.)|Gross Margin Cabaletta Bio CABA|VTYX: Return on Gross Profit|Theratechnologies Inc. (THTX) - Return on Gross Profit|AVTX: Gross Margin|ELDN - Return on Sales by Gross Profit|AGEN (Agenus, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability